News | June 24, 2014

Study Shows Promise for Speckle-tracking Echo After Transcatheter Pulmonary Valve Implantation

June 24, 2014 — Researchers have announced the results of a study that used speckle-tracking echocardiography (STE) to analyze early phase one results from the multi-center COMPASSION trial, which seeks to examine the safety and efficacy of a new option to replace dysfunctional pulmonary valves in a subset of congenital heart disease patients. Traditional echocardiography has been an excellent diagnostic tool for decades, providing a safe, cost-effective and non-invasive way to guide treatment for a wide variety of heart disease patients. Advances in ultrasound technology in recent years, such as STE, continue to expand echo’s capabilities and increase its value in modern healthcare.

“Congenital heart disease patients now survive much longer than in the past, but often experience secondary heart problems later in life, such as pulmonary valve dysfunction. The COMPASSION trial is showing promising early results, and our study suggests that speckle-tracking echocardiography (STE) may be a more sensitive tool than traditional echo or MRI to predict outcomes in these patients,” said primary investigator Shahryar M. Chowdhury, M.D. Chowdhury is an instructor of pediatric cardiology at the Medical University of South Carolina (MUSC); he and his colleagues sought to evaluate the correlation between changes in STE measures of right ventricular (RV) function and changes in measures of exercise function after Sapien transcatheter pulmonary valve (TPV) implantation.

Researchers on the study, “Changes in Speckle-Tracking Echocardiographic Measures of Right Ventricular Function Correlate with Changes in Measures of Exercise Function after Percutaneous Implantation of the Edwards Sapien Transcatheter Heart Valve in the Pulmonary Position,” included Shahryar M. Chowdhury from the Medical University of South Carolina in Charleston, S.C.; Ziyad M. Hijazi and Qi-Ling Cao from Rush University Medical Center in Chicago; John T. Fahey from Yale-New Haven Hospital in New Haven, Conn.; John F. Rhodes from Miami Children's Hospital in Miami; Saibal Kar and Raj Makkar from Cedar Sinai Medical Center in Los Angeles; Michael Mullen from The Heart Hospital in London, United Kingdom; Kyle Bilhorn and Lazar Mandinov from Edwards Lifesciences LLC in Irvine, Calif.; and Girish S. Shirali from Children’s Mercy Hospital in Kansas City, Mo..

For more information: www.asecho.org

Related Content

FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...
360 Photos | Ultrasound Imaging | July 08, 2019
This is a 360 degree view of a live cardiac echo demonstration for the Siemens Healthineers Acuson SC2000...
3D Auto RV application image courtesy of Philips Healthcare

3D Auto RV application image courtesy of Philips Healthcare

Technology | Cardiovascular Ultrasound | July 02, 2019
Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac ultrasound...
Konica Minolta Healthcare Partners With DiA Imaging Analysis for AI-based Cardiac Ultrasound Analysis
News | Cardiovascular Ultrasound | July 02, 2019
DiA Imaging Analysis has partnered with Konica Minolta Healthcare Americas Inc. to expand analysis capabilities of...
The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

The Acuson Sequoia with Deep Abdominal Transducer (DAX) scanning a 600 pound patient.

Sponsored Content | Case Study | Ultrasound Imaging | July 01, 2019
“With our present technology, we often struggle with large patients,” said Richard G.
FDA Issues Final Guidance on Marketing Clearance of Diagnostic Ultrasound Systems and Transducers
News | Ultrasound Imaging | June 27, 2019
The U.S. Food and Drug Administration (FDA) issued the final guidance: Marketing Clearance of Diagnostic Ultrasound...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...